r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
A side-by-side editorial comparison of DoseFinding and ymlthis — release velocity, themes, recent moves, and the top alternatives to consider.
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
ymlthis retired itself, naming Quarto as the reason it no longer needs to exist.
ymlthis built R Markdown YAML front matter programmatically — a fluent `yml_*()` interface plus RStudio add-ins, so users did not have to hand-write metadata blocks whose valid fields were scattered across output-format documentation. Version 1.0.0 declares the package retired, with only CRAN-preserving changes to follow, and states the reason plainly: Quarto now provides good YAML support.
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
ymlthis built R Markdown YAML front matter programmatically — a fluent `yml_*()` interface plus RStudio add-ins, so users did not have to hand-write metadata blocks whose valid fields were scattered across output-format documentation. Version 1.0.0 declares the package retired, with only CRAN-preserving changes to follow, and states the reason plainly: Quarto now provides good YAML support.
The retirement is the endpoint of a long drift. Between 2020 and 2022 every release was reactive — patching around a crayon update that mangled rendered YAML, tracking shiny 1.6, following roxygen2 7.0.0, fixing a typo in an add-in. No new capability has landed in six years, and the four-year gap before 1.0.0 had already answered the question the release note finally makes explicit.
Nothing further of substance is expected — the stated policy is changes only where CRAN requires them, so the next release, if any, will be a compatibility patch.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or ymlthis.
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul took mocking back from webmockr and made it a property of the client itself
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
Six years since the last functional change, and Google renamed the service it wraps in the release before that
See all DoseFinding alternatives → · See all ymlthis alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and ymlthis are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and ymlthis are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
Top ymlthis alternatives in Analytics are ranked by recent ship velocity. Browse the "ymlthis alternatives" section above for the current picks, or visit /alternatives/ymlthis for the full list with editorial commentary on each.